These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7810357)

  • 1. Use of transdermal nicotine systems in a possible suicide attempt.
    Montalto N; Brackett CC; Sobol T
    J Am Board Fam Pract; 1994; 7(5):417-20. PubMed ID: 7810357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An attempted suicide using transdermal nicotine patches.
    Labelle A; Boulay LJ
    Can J Psychiatry; 1999 Mar; 44(2):190. PubMed ID: 10097845
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-poisoning among adults using multiple transdermal nicotine patches.
    Woolf A; Burkhart K; Caraccio T; Litovitz T
    J Toxicol Clin Toxicol; 1996; 34(6):691-8. PubMed ID: 8941198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Childhood poisoning involving transdermal nicotine patches.
    Woolf A; Burkhart K; Caraccio T; Litovitz T
    Pediatrics; 1997 May; 99(5):E4. PubMed ID: 9113961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can transdermal nicotine patch cause acute intoxication in a child? A case report and review of literature.
    Wain AA; Martin J
    Ulster Med J; 2004 May; 73(1):65-6. PubMed ID: 15244132
    [No Abstract]   [Full Text] [Related]  

  • 6. Suicide plan by nicotine poisoning: a review of nicotine toxicity.
    Saxena K; Scheman A
    Vet Hum Toxicol; 1985 Dec; 27(6):495-7. PubMed ID: 4082460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicide attempts and the nicotine patch.
    Engel CJ; Parmentier AH
    JAMA; 1993 Jul; 270(3):323-4. PubMed ID: 8315774
    [No Abstract]   [Full Text] [Related]  

  • 8. Transdermal fentanyl in deliberate overdose in pediatrics.
    Lyttle MD; Verma S; Isaac R
    Pediatr Emerg Care; 2012 May; 28(5):463-4. PubMed ID: 22561319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial.
    Yudkin PL; Jones L; Lancaster T; Fowler GH
    Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of chronopharmacokinetics in design and evaluation of transdermal drug delivery systems.
    Gries JM; Benowitz N; Verotta D
    J Pharmacol Exp Ther; 1998 May; 285(2):457-63. PubMed ID: 9580583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prescription of transdermal nicotine patches for tobacco-using dental patients: current status in Indiana.
    Christen AG; Christen JA
    J Indiana Dent Assoc; 1992; 71(6):12-8. PubMed ID: 1341696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case report: Two severe cases of suicide attempts using nicotine containing e-cigarette liquid.
    Jalkanen V; Värelä V; Kalliomäki J
    Duodecim; 2016; 132(16):1480-3. PubMed ID: 29188936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transdermal nicotine on inspection time.
    Thompson JC; Wilby G; Stough C
    Hum Psychopharmacol; 2002 Apr; 17(3):157-61. PubMed ID: 12404693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a novel prolonged-release nicotine transdermal patch.
    Davaran S; Rashidi MR; Khandaghi R; Hashemi M
    Pharmacol Res; 2005 Mar; 51(3):233-7. PubMed ID: 15661573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users.
    Orleans CT; Resch N; Noll E; Keintz MK; Rimer BK; Brown TV; Snedden TM
    JAMA; 1994 Feb; 271(8):601-7. PubMed ID: 8301792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Suicide attempts by young adolescents: epidemiological characteristics of 517 15-year-old or younger adolescents admitted in French emergency departments].
    Giraud P; Fortanier C; Fabre G; Ghariani J; Guillermain Y; Rouviere N; Chabrol B; Jouve JL; Simeoni MC
    Arch Pediatr; 2013 Jun; 20(6):608-15. PubMed ID: 23628122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and perceptions of nicotine patch users.
    Haxby D; Sinclair A; Eiff MP; McQueen MH; Toffler WL
    J Fam Pract; 1994 May; 38(5):459-64. PubMed ID: 8176343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling.
    Sachs DP; Säwe U; Leischow SJ
    Arch Intern Med; 1993 Aug; 153(16):1881-90. PubMed ID: 8110249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeability test for transdermal and local therapeutic patches using Skin PAMPA method.
    Vizserálek G; Berkó S; Tóth G; Balogh R; Budai-Szűcs M; Csányi E; Sinkó B; Takács-Novák K
    Eur J Pharm Sci; 2015 Aug; 76():165-72. PubMed ID: 25957747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of the contact sensitization potential of a transdermal nicotine system (Nicoderm).
    Jordan WP
    J Fam Pract; 1992 Jun; 34(6):709-12. PubMed ID: 1593244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.